Literature DB >> 9786903

Interconversion of the kinetic identities of the tandem catalytic domains of receptor-like protein-tyrosine phosphatase PTPalpha by two point mutations is synergistic and substrate-dependent.

K L Lim1, P R Kolatkar, K P Ng, C H Ng, C J Pallen.   

Abstract

The two tandem homologous catalytic domains of PTPalpha possess different kinetic properties, with the membrane proximal domain (D1) exhibiting much higher activity than the membrane distal (D2) domain. Sequence alignment of PTPalpha-D1 and -D2 with the D1 domains of other receptor-like PTPs, and modeling of the PTPalpha-D1 and -D2 structures, identified two non-conserved amino acids in PTPalpha-D2 that may account for its low activity. Mutation of each residue (Val-536 or Glu-671) to conform to its invariant counterpart in PTPalpha-D1 positively affected the catalytic efficiency of PTPalpha-D2 toward the in vitro substrates para-nitrophenylphosphate and the phosphotyrosyl-peptide RR-src. Together, they synergistically transformed PTPalpha-D2 into a phosphatase with catalytic efficiency for para-nitrophenylphosphate equal to PTPalpha-D1 but not approaching that of PTPalpha-D1 for the more complex substrate RR-src. In vivo, no gain in D2 activity toward p59(fyn) was effected by the double mutation. Alteration of the two corresponding invariant residues in PTPalpha-D1 to those in D2 conferred D2-like kinetics toward all substrates. Thus, these two amino acids are critical for interaction with phosphotyrosine but not sufficient to supply PTPalpha-D2 with a D1-like substrate specificity for elements of the phosphotyrosine microenvironment present in RR-src and p59(fyn). Whether the structural features of D2 can uniquely accommodate a specific phosphoprotein substrate or whether D2 has an alternate function in PTPalpha remains an open question.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9786903     DOI: 10.1074/jbc.273.44.28986

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

Review 1.  Structural and evolutionary relationships among protein tyrosine phosphatase domains.

Authors:  J N Andersen; O H Mortensen; G H Peters; P G Drake; L F Iversen; O H Olsen; P G Jansen; H S Andersen; N K Tonks; N P Møller
Journal:  Mol Cell Biol       Date:  2001-11       Impact factor: 4.272

2.  Dimerization in vivo and inhibition of the nonreceptor form of protein tyrosine phosphatase epsilon.

Authors:  Hila Toledano-Katchalski; Zohar Tiran; Tal Sines; Gidi Shani; Shira Granot-Attas; Jeroen den Hertog; Ari Elson
Journal:  Mol Cell Biol       Date:  2003-08       Impact factor: 4.272

3.  Receptor type protein tyrosine phosphatases (RPTPs) - roles in signal transduction and human disease.

Authors:  Yiru Xu; Gary J Fisher
Journal:  J Cell Commun Signal       Date:  2012-08-01       Impact factor: 5.782

4.  Regulation of receptor protein-tyrosine phosphatase alpha by oxidative stress.

Authors:  Christophe Blanchetot; Leon G J Tertoolen; Jeroen den Hertog
Journal:  EMBO J       Date:  2002-02-15       Impact factor: 11.598

5.  Receptor-like protein tyrosine phosphatase alpha homodimerizes on the cell surface.

Authors:  G Jiang; J den Hertog; T Hunter
Journal:  Mol Cell Biol       Date:  2000-08       Impact factor: 4.272

6.  High-resolution crystal structures of the D1 and D2 domains of protein tyrosine phosphatase epsilon for structure-based drug design.

Authors:  George T Lountos; Sreejith Raran-Kurussi; Bryan M Zhao; Beverly K Dyas; Terrence R Burke; Robert G Ulrich; David S Waugh
Journal:  Acta Crystallogr D Struct Biol       Date:  2018-10-02       Impact factor: 7.652

7.  Gain control of N-methyl-D-aspartate receptor activity by receptor-like protein tyrosine phosphatase alpha.

Authors:  Gang Lei; Sheng Xue; Nadège Chéry; Qiang Liu; Jindong Xu; Chun L Kwan; Yang-Ping Fu; You-Ming Lu; Mingyao Liu; Kenneth W Harder; Xian-Min Yu
Journal:  EMBO J       Date:  2002-06-17       Impact factor: 11.598

8.  Structural basis for the function and regulation of the receptor protein tyrosine phosphatase CD45.

Authors:  Hyun-Joo Nam; Florence Poy; Haruo Saito; Christin A Frederick
Journal:  J Exp Med       Date:  2005-01-31       Impact factor: 14.307

9.  Receptor-type protein tyrosine phosphatase alpha (PTPα) mediates MMP14 localization and facilitates triple-negative breast cancer cell invasion.

Authors:  Lisa R Decotret; Brennan J Wadsworth; Ling Vicky Li; Chinten J Lim; Kevin L Bennewith; Catherine J Pallen
Journal:  Mol Biol Cell       Date:  2021-02-10       Impact factor: 4.138

10.  PTP alpha regulates integrin-stimulated FAK autophosphorylation and cytoskeletal rearrangement in cell spreading and migration.

Authors:  Li Zeng; Xiaoning Si; Wei-Ping Yu; Hoa Thi Le; Kwok Peng Ng; Raymond M H Teng; Kenneth Ryan; Dennis Z-M Wang; Sathivel Ponniah; Catherine J Pallen
Journal:  J Cell Biol       Date:  2003-01-06       Impact factor: 10.539

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.